Denk Pharma
Ulrich Deutschmann is an experienced executive in the pharmaceuticals and consulting industries, currently serving as Chief Revenue Officer and a member of the Leadership Team at Denk Pharma GmbH & Co. KG since February 2023, where leadership is provided to over 550 sales managers across more than 85 countries. Prior roles include Chief Commercial Officer at DFE Pharma, where Ulrich led global sales and marketing efforts, and Senior Vice President of Global Business Transformation at Apotex Inc., focusing on strategic planning and transformation initiatives. Additional experience encompasses leadership positions at Sandoz and consulting roles at The Boston Consulting Group and Kearney, emphasizing strategy, change management, and operations across various industries, particularly in Asia. Ulrich's educational background includes advanced studies in industrial marketing strategy from INSEAD and law degrees from Universität Passau and Freestate of Bavaria.
This person is not in any teams
This person is not in any offices
Denk Pharma
Denk Pharma is a pharmaceutical company operating in more than 80 countries. Our Purpose "We create access to healing in emerging markets" drives our actions. Since 1948, we have therefore been offering our patients worldwide the same high quality of our medicines and nutritional supplements that can be found in every German pharmacy. To ensure this, our products are approved, manufactured and quality-controlled in Germany according to the promise "Quality for your health - Made in Germany". In addition, we offer services and information that contribute to the correct diagnosis of diseases and application of the products, thus providing our patients worldwide with access to healing.